(Allergan plc)

	AGN latest price $160.6311 (-1.57%) ($156.5146 - $161.8044) on Tue. Dec. 5, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.81% (three month average)
RSI	41
Latest Price	$160.6311(-1.57%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.9% a day on average for past five trading days.
Weekly Trend	AGN declines -0.9% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(50%)    XBI(46%)    ARKG(45%)    IVE(45%)
Factors Impacting AGN price	AGN will decline at least -0.905% in a week (0% probabilities).   VIXM(-30%)    TLT(-19%)    UUP(-17%)    GDXJ(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.905% (StdDev 1.81%)
Hourly BBV	0 ()
Intraday Trend	0.6%

Resistance Level	$168.22
5 Day Moving Average	$166.35(-3.44%)
10 Day Moving Average	$167.46(-4.08%)
20 Day Moving Average	$168.22(-4.51%)
To recent high	-29.4%
To recent low	0%
Market Cap	$52.96b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed